Trial Profile
Symbicort and health economics in a real life evaluation - SHARE - A randomised, open-label, parallel-group, multicentre study to assess the asthma-related health-care costs, in ordinary clinical practice during 12 months.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Feb 2011
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary) ; Budesonide; Formoterol; Terbutaline
- Indications Asthma
- Focus Therapeutic Use
- Acronyms SHARE
- Sponsors AstraZeneca
- 08 Oct 2008 Results presented at ERS in Oct 2008.
- 01 Oct 2008 Results published in Respiratory Medicine.
- 11 Jan 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.